BioSpace News Archive

BioCapital

NextCure to Present at the BofA Securities 2022 Healthcare Conference

NextCure, Inc. today announced that it will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference in Las Vegas on Tuesday May 10th at 10:40 am PT.

May 3, 2022
·
2 min read
Genetown

Ring Therapeutics Announces Two Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Ring Therapeutics today announced two upcoming presentations at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), to be held from May 16-19, 2022 in Washington, DC.

May 3, 2022
·
2 min read
Genetown

Sesen Bio Provides Strategic Update

Sesen Bio today announced that it has initiated a process to review strategic alternatives with the goal of maximizing shareholder value.

May 3, 2022
·
8 min read
Business

Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer

Seismic Therapeutic, Inc. today announced the appointment of Maude Tessier, PhD, as Chief Business Officer.

May 3, 2022
·
3 min read
Business

Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets

Cerus Corporation (Nasdaq: CERS) today announced that it has signed a ten-year agreement with Fresenius Kabi for the production of INTERCEPT Blood System sets.

May 3, 2022
·
3 min read
Genetown

Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022

Pressure BioSciences, Inc. today announced the Company’s participation as a presenter at the May 3-5 Planet MicroCap Showcase 2022.

May 3, 2022
·
5 min read
Pharm Country

U.S. FDA Accepts Supplemental New Drug Application (sNDA) and Grants Priority Review for NUBEQA® (darolutamide) in Combination with Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Bayer today announced the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for the oral androgen receptor inhibitor (ARi) NUBEQA ® .

May 3, 2022
·
10 min read
Business

UroGen Pharma to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022

UroGen Pharma Ltd. today announced that it will report first quarter 2022 financial results on Tuesday, May 10, 2022, prior to the open of the market.

May 3, 2022
·
1 min read
Business

Yield10 Bioscience to Announce First Quarter 2022 Financial Results and Host a Conference Call on Wednesday, May 11, 2022

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2022 financial results and provide a corporate update on Wednesday, May 11, 2022.

May 3, 2022
·
1 min read
Business

CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12

CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2022, after the market close on Thursday, May 12, 2022, and will host a corporate update conference call at 4:30pm Eastern Time.

May 3, 2022
·
2 min read